Episodes

  • 48: What does the future of EIS look like?

    48: What does the future of EIS look like?
    Jul 29 2024
    Christiana Stewart-Lockhart (Director General of the Enterprise Investment Scheme Association (EISA)) joins the Deepbridge Discovery Podcast to discuss the work she does at EISA, what the future of EIS looks like, what she would change about EIS if she was the government, and more!
    Show More Show Less
    42 mins
  • 47: What does Glyconics do?

    47: What does Glyconics do?
    Jul 2 2024
    Kam Pooni (CEO at Glyconicss) joins the Deepbridge Discovery Podcast to discuss the work he does at Glyconics, how the company came to be, the plans to scale and commercialise the business and how Deepbridge Capital has supported Glyconics.
    Show More Show Less
    42 mins
  • 46: Thinking Machine Systems Hopes For Future

    46: Thinking Machine Systems Hopes For Future
    Jun 4 2024
    Richard Martin (Founder at Thinking Machine Systems) joins the Deepbridge Discovery Podcast to discuss the work he does at Thinking Machine Systems, the plans to scale the business, what the market is like at the moment and why Thinking Machine Systems chose EIS through Deepbridge Capital.
    Show More Show Less
    35 mins
  • 45: What does the Earthshot Prize mean for ENSO?

    45: What does the Earthshot Prize mean for ENSO?
    May 13 2024
    Gunnlaugur "G" Erlendsson (CEO at ENSO) joins the Deepbridge Discovery Podcast to discuss the work he does at ENSO, what the Earthshot Prize is and what it means for an early stage business like ENSO.


    Show More Show Less
    48 mins
  • 44: Why is Renewable Energy an exciting asset class?

    44: Why is Renewable Energy an exciting asset class?
    Apr 30 2024
    Chris Caldwell (CEO at United Renewables) joins the Deepbridge Discovery Podcast to discuss the work he does as Deepbridge's lead development partner in Northern Ireland, why he went into the renewables industry, what the market is like at the moment and what he thinks some of the biggest industry challenges are at the moment and how they can be addressed.
    Show More Show Less
    43 mins
  • 43: What do Investor Ladder and Climb24 do?

    43: What do Investor Ladder and Climb24 do?
    Apr 15 2024
    Gordon Bateman (CEO at CRSI) joins the Deepbridge Discovery Podcast to discuss what Investor Ladder and Climb24 do, what his role is at these companies, what some of the biggest challenges are in our industry as a whole, and how he thinks they can be addressed, joined by Andrew Aldridge and Olivia Drinnan.

    About CRSI:
    At CRSI, our goal is to help you to build the most exciting, forward-thinking business and we thrive on playing a key role in your long-term success.

    We work exclusively with the most active investors and their portfolio businesses, providing a range of specialist services including executive search, management due-diligence, organisational design, skills gap analysis, recruitment, and HR strategy.

    Since the business was founded, we have built an amazing team of dedicated, passionate high-calibre individuals, and invest heavily in continual development and training in order to ensure that we are all able to consistently provide the highest level of service to our clients.

    In addition, we have built strategic relationships with a small number of best-of-breed partners (who have real proven experience working with high-grwoth investor-backed businesses) to allow CRSI to broaden our service offerings, providing a more comprehensive service to our customers.

    The team is continually growing, and I am always very interested in meeting bright, driven, focused individuals at all levels who want to make a real difference to some of the most exciting businesses in the UK.
    Show More Show Less
    41 mins
  • 42: Propifi Joins the Deepbridge Discovery Podcast

    42: Propifi Joins the Deepbridge Discovery Podcast
    Mar 6 2024
    Rodney Black (CEO at Propifi) joins the Deepbridge Discovery Podcast to discuss his background, the types of organisations that Propifi lend to and why the state at which they lend is particularly interesting and Mike McWilliam (Regional Director - Scotland & Northern Ireland) joins to discuss how the lending Propifi does may be an appealing asset class for a Business Relief solution.

    About Propifi:
    Propifi are here to assist companies and individuals with short term financing until permanent financing is secured.
    Before the credit crunch in 2008 bridging finance was only offered by a small number of specialist lenders.

    As mainstream banks tightened up their lending criteria, a gap in the market developed to assist those homeowners and landlords looking for short-term finance. Bridging provided quick access to finance for those wishing to buy a new property before completing the sale of an existing one. Bridging finance has now evolved to provide property developers a similar advantage.

    The UK bridging market is currently worth £4.5bn, a large proportion of this relates to property developers looking to progress developments with bridging finance.
    Show More Show Less
    34 mins
  • 41: What is Antimicrobial Resistance?

    41: What is Antimicrobial Resistance?
    Oct 31 2023
    Why should we be worried about resistance to antibodies?

    Neciah Dorh (CEO at FluoretiQ Limited) joins the Deepbridge Discovery Podcast to discuss his background, why antimicrobial resistance was declared as the biggest health challenge of the 21st century by WHO, what his next steps and goals are and the challenges he has faced.

    About FluoretiQ Limited:
    We develop diagnostics that are fast, accurate and can be used at the point of care: ensuring the first prescription, is always the right prescription. 

    Our technologies answer 2 vital questions to ensure effective and sustainable use of antibiotics:

    Does the patient have an infection treatable with antibiotics?
    NANOPLEX® is an advanced latex agglutination test that can be used to rapidly identify and quantify the cause of infection in 5 minutes. 

    What will be the most effective antibiotic treatment?
    SCFI™ is a phenotypic, real-time and growth-free antibiotic susceptibility test that determines the most effective antibiotic in 30 minutes. 

    - - -

    Supporting growth-focused companies and entrepreneurs has never been more important, but it is important to understand the people and ideas behind such investment opportunities.  

    Join the Deepbridge Capital team each week as they discuss all things Deepbridge, speak with various investment experts within the company and discover more about the founders and CEOs’ running the portfolio companies Deepbridge invests in. Each episode contains an informal conversation to understand how these leaders and teams perform in order to achieve their goals. Investments in early-stage companies are illiquid and high risk – investors could lose all of their capital. 
    Show More Show Less
    25 mins